MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 70 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $108 | -44.0% | 7,348 | -48.9% | 0.00% | – |
| Q4 2023 | $193 | +739.1% | 14,380 | +679.4% | 0.00% | – |
| Q3 2023 | $23 | -66.7% | 1,845 | -67.2% | 0.00% | – |
| Q2 2023 | $69 | +3.0% | 5,617 | +3.3% | 0.00% | – |
| Q1 2023 | $67 | +3250.0% | 5,438 | +3928.1% | 0.00% | – |
| Q4 2022 | $2 | -99.9% | 135 | -57.8% | 0.00% | – |
| Q1 2021 | $2,000 | – | 320 | +3900.0% | 0.00% | – |
| Q4 2019 | $0 | – | 8 | -84.0% | 0.00% | – |
| Q3 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 50 | -93.3% | 0.00% | – |
| Q3 2018 | $4,000 | -95.7% | 750 | -96.0% | 0.00% | – |
| Q2 2018 | $92,000 | +338.1% | 18,714 | +599.6% | 0.00% | – |
| Q1 2018 | $21,000 | -16.0% | 2,675 | +9.4% | 0.00% | – |
| Q4 2017 | $25,000 | +525.0% | 2,445 | +720.5% | 0.00% | – |
| Q3 2017 | $4,000 | – | 298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rise Advisors, LLC | 272 | $4,108 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 318,995 | $4,826,394 | 0.00% |
| Covestor Ltd | 106 | $0 | 0.00% |
| Farther Finance Advisors, LLC | 77 | $0 | 0.00% |
| JBF Capital, Inc. | 39,637 | $1,189 | 0.00% |
| GOLDMAN SACHS GROUP INC | 29,807 | $450,980 | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 15 | $0 | 0.00% |
| CWM, LLC | 22 | $0 | 0.00% |
| CALDWELL SUTTER CAPITAL, INC. | 7,458 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 2,480 | $37,519 | 0.00% |